Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book
the period ended (Kiosk) 129,948 130,109 130,053 129,208 129,011 Total average number of money transfer transactions (per day) 27,287 28,689 30,006 30,553 31,813 In 2Q19, FSMART is able to maintain as
/2017 4/2017 1/2018 2/2018 Total usage amount through "Boonterm Kiosk" (Million Baht) 8,779 9,311 10,084 10,421 10,611 Total number of "Boonterm Kiosk" as the period ended (Kiosk) 110,563 119,166 124,653
9.05 5.71 7.77 (0.97) 14.52 Profit before income tax expenses 34.41 46.63 23.08 31.41 (11.33) 32.93 Income tax expenses 3.57 4.84 3.95 5.38 0.38 10.64 Profit for the period 30.84 41.79 19.13 26.04 (11.71
consolidated basis as of 30th September 2018, is less than 15% and the total size of all transactions within the past 6-month period does not exceed 15%, the Company has no duty to disclose the transaction under
construction. 37.5 By cash (Paying in instalments of approximately 20 percent of the purchase price during construction period, and paying the remaining amount upon the transfer of the ownership of the ERU
ซื้อทรัพย์สินใหม่ภำคเอกชนเห็นว่ำ ควรใช้หลักเกณฑ์ กำรอนุญำตเช่นเดียวกับกำรแปลงสภำพกอง 1 เป็น REIT แบบ 1: 1 เช่น ไม่ต้องมีที่ปรึกษำทำงกำรเงิน ไม่ม ีunderwriter และมี cooling period เพียง 1 วัน ซึ่งส ำนักงำ
to sales ratio increased from 26.4% in 3Q 2018 to 32.0% in this quarter. During this period, the Company’s media operation in Malaysia market reached its break-even of net profit for the first time
cash flows financing activities 5,584 Net increase in cash and cash equivalents 5,780 Cash and cash equivalents at beginning of period 704 Cash and cash equivalents at end of period 6,484 (Translation